Page last updated: 2024-09-02

sr 95531 and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one

sr 95531 has been researched along with 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one in 1 studies

Compound Research Comparison

Studies
(sr 95531)
Trials
(sr 95531)
Recent Studies (post-2010)
(sr 95531)
Studies
(2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one)
Trials
(2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one)
Recent Studies (post-2010) (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one)
610020918401

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babich, M; Branda, EM; Elfline, GS; Quock, RM1

Other Studies

1 other study(ies) available for sr 95531 and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one

ArticleYear
Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:8

    Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; GABA Agonists; GABA-A Receptor Agonists; Injections, Intraventricular; Isoxazoles; Male; Mice; Nitric Oxide Synthase; Nitroarginine; Pyrazoles; Pyridazines

2004